In-House Patent Attorney, Biotechnology, London
Silence Therapeutics is poised at an exciting time in its growth, and is expanding its IP portfolio. As Silence intensifies its efforts in the field of RNAi Therapeutics, and is the only European listed organisation in the field, there is need for additional resource within its IP function.
Silence Therapeutics are able to offer a patent attorney opportunity that is highly varied and will require European travel. You will work very closely with R&D departments and enjoy a collaborative environment where you will develop IP strategies in conjunction with scientific staff.
Key responsibilities include:
Candidates should be either qualified UK and European patent attorneys, or near qualified (finalist) with the expectation of qualification within the next year to eighteen months. Attorneys should have an academic and technical background in biotechnology.
About Silence Therapeutics
Silence Therapeutics develops a new generation of medicines by harnessing the body’s natural mechanism of RNA interference, or RNAi, within its cells. Their proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease causing proteins. Using their enabling delivery systems, they have achieved an additional level of specificity by delivering therapeutic RNA molecules exclusively to target cells. Silence’s proprietary RNA chemistries and delivery systems are designed to improve the stability of their molecules and enhance effective delivery to target cells, providing a powerful modular technology well suited to tackle life threatening diseases.
The company is located in London and Berlin with a total of around 55 employees. The majority of the scientific operation and employee base is located in Berlin with corporate headquarters in London.
For more information or to apply to this role please send an email to firstname.lastname@example.org or telephone +44 20 7903 5019.